BP003592: Cynomolgus GPRC5D Protein-VLP
Source: The recombinant Cynomolgus GPRC5D Protein-VLP, (amino acids Met1-Cys300) , was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus GPRC5D VLP (100 ul/well) at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-GPRC5D Antibody, hFc tag with the EC50 of 6.91 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005191: Human GPRC5D Protein-VLP
Source: The recombinant Human GPRC5D Protein-VLP, (amino acids Met1-Val345) , was produced in HEK 293 cells.
Activity: Immobilized recombinant Human GPRC5D VLP at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-GPRC5D Antibody, hFc tag with the EC50 of 3.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003589: Mouse GPRC5D Protein-VLP
Source: The recombinant Mouse GPRC5D Protein-VLP, (amino acids Met1-Leu344) , was produced in HEK 293 cells.
Activity: Immobilized recombinant Mouse GPRC5D VLP (100 ul/well) at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-GPRC5D Antibody, hFc tag with the EC50 of 5.7 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.